Endoscopic therapy for weight loss: Gastroplasty, duodenal sleeves, intragastric balloons, and aspiration
Author:
Open Access
- 1 January 2015
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Endoscopy
- Vol. 7 (9) , 847-59
Abstract
A new paradigm in the treatment of obesity and metabolic disease is developing. The global obesity epidemic continues to expand despite the availability of diet and lifestyle counseling, pharmacologic therapy, and weight loss surgery. Endoscopic procedures have the potential to bridge the gap between medical therapy and surgery. Current primary endoscopic bariatric therapies can be classified as restrictive, bypass, space-occupying, or aspiration therapy. Restrictive procedures include the USGI Primary Obesity Surgery Endolumenal procedure, endoscopic sleeve gastroplasty using Apollo OverStitch, TransOral GAstroplasty, gastric volume reduction using the ACE stapler, and insertion of the TERIS restrictive device. Intestinal bypass has been reported using the EndoBarrier duodenal-jejunal bypass liner. A number of space-occupying devices have been studied or are in use, including intragastric balloons (Orbera, Reshape Duo, Heliosphere BAG, Obalon), Transpyloric Shuttle, and SatiSphere. The AspireAssist aspiration system has demonstrated efficacy. Finally, endoscopic revision of gastric bypass to address weight regain has been studied using Apollo OverStitch, the USGI Incisionless Operating Platform Revision Obesity Surgery Endolumenal procedure, Stomaphyx, and endoscopic sclerotherapy. Endoscopic therapies for weight loss are potentially reversible, repeatable, less invasive, and lower cost than various medical and surgical alternatives. Given the variety of devices under development, in clinical trials, and currently in use, patients will have multiple endoscopic options with greater efficacy than medical therapy, and with lower invasiveness and greater accessibility than surgery.Keywords
This publication has 61 references indexed in Scilit:
- Long-term follow-up evaluation of endoscopic sclerotherapy for dilated gastrojejunostomy after gastric bypassSurgical Endoscopy, 2014
- Endoscopic sclerotherapy for the treatment of weight regain after Roux-en-Y gastric bypass: outcomes, complications, and predictors of response in 575 proceduresGastrointestinal Endoscopy, 2012
- Incisionless revision of post-Roux-en-Y bypass stomal and pouch dilation: multicenter registry resultsSurgery for Obesity and Related Diseases, 2010
- Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patientsGastrointestinal Endoscopy, 2010
- BioEnterics® Intragastric Balloon (BIB®). Single Ambulatory Center Spanish Experience with 714 Consecutive Patients Treated with One or Two Consecutive BalloonsObesity Surgery, 2010
- Early Results of Trans-Oral Endoscopic Plication and Revision of the Gastric Pouch and Stoma following Roux-en-Y Gastric Bypass SurgeryJSLS : Journal of the Society of Laparoscopic & Robotic Surgeons, 2010
- Treatment of weight regain after gastric bypass surgery when using a new endoscopic platform: initial experience and early outcomes (with video)Gastrointestinal Endoscopy, 2009
- Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter studySurgical Endoscopy, 2007
- BioEnterics Intragastric Balloon: The Italian Experience with 2,515 PatientsObesity Surgery, 2005
- What’s in a Name? In Search of Leptin’s Physiologic Role1The Journal of Clinical Endocrinology & Metabolism, 1998